Magnetic Resonance Spectroscopy for Psychiatry

2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1

2016, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1545, 10.1016/S0140-6736(16)31678-6

American Psychiatric Association, 2013

Gong, 2016, A selective review of cerebral abnormalities in patients with first-episode schizophrenia before and after treatment, Am J Psychiatry, 173, 232, 10.1176/appi.ajp.2015.15050641

Huang, 2019, Progress in psychoradiology, the clinical application of psychiatric neuroimaging, Br J Radiol, 92, 20181000, 10.1259/bjr.20181000

Port, 2009, Magnetic resonance spectroscopy in psychiatry, 566

American Psychiatric Association, 2000

Insel, 2013

Insel, 2010, Research domain criteria (RDoC): toward a new classification framework for research on mental disorders, Am J Psychiatry, 167, 748, 10.1176/appi.ajp.2010.09091379

Carcone, 2017, Six years of research on the national institute of mental health's research domain criteria (RDoC) initiative: a systematic review, Front Cell Neurosci, 11, 46, 10.3389/fncel.2017.00046

Bak, 2006, The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer, J Neurochem, 98, 641, 10.1111/j.1471-4159.2006.03913.x

Featherstone, 2010, Intercellular glutamate signaling in the nervous system and beyond, ACS Chem Neurosci, 1, 4, 10.1021/cn900006n

Frahm, 1987, Localized proton spectroscopy using stimulated echoes, J Magn Reson, 72, 502

Bottomley, 1987, Spatial localization in NMR spectroscopy in vivo, Ann N Y Acad Sci, 508, 333, 10.1111/j.1749-6632.1987.tb32915.x

Moonen, 1989, Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy, NMR Biomed, 2, 201, 10.1002/nbm.1940020506

Hancu, 2009, Optimized glutamate detection at 3T, J Magn Reson Imaging, 30, 1155, 10.1002/jmri.21936

Mescher, 1996, Solvent suppression using selective echo dephasing, J Magn Reson, 123, 226

Mullins, 2014, Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA, Neuroimage, 86, 43, 10.1016/j.neuroimage.2012.12.004

Henning, 2018, Proton and multinuclear magnetic resonance spectroscopy in the human brain at ultra-high field strength: a review, Neuroimage, 168, 181, 10.1016/j.neuroimage.2017.07.017

Jansen, 2006, 1H MR spectroscopy of the brain: absolute quantification of metabolites, Radiology, 240, 318, 10.1148/radiol.2402050314

Quadrelli, 2016, Hitchhiker's guide to voxel segmentation for partial volume correction of in vivo magnetic resonance spectroscopy, Magn Reson Insights, 1

Mierisova, 2001, MR spectroscopy quantitation: a review of frequency domain methods, NMR Biomed, 14, 247, 10.1002/nbm.697

Merritt, 2016, Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies, JAMA Psychiatry, 73, 665, 10.1001/jamapsychiatry.2016.0442

Glausier, 2017, GABA and schizophrenia: Where we stand and where we need to go, Schizophr Res, 181, 2, 10.1016/j.schres.2017.01.050

Egerton, 2017, Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis, Transl Psychiatry, 7, e1147, 10.1038/tp.2017.124

Schür, 2016, Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of (1) H-MRS studies, Hum Brain Mapp, 37, 3337, 10.1002/hbm.23244

Brugger, 2011, Proton magnetic resonance spectroscopy and illness stage in schizophrenia–a systematic review and meta-analysis, Biol Psychiatry, 69, 495, 10.1016/j.biopsych.2010.10.004

Iwata, 2018, Neurometabolite levels in antipsychotic-naive/free patients with schizophrenia: a systematic review and meta-analysis of 1H-MRS studies, Prog Neuropsychopharmacol Biol Psychiatry, 86, 340, 10.1016/j.pnpbp.2018.03.016

Moriguchi, 2019, Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies, Mol Psychiatry, 24, 952, 10.1038/s41380-018-0252-9

Gigante, 2012, Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis, Bipolar Disord, 14, 478, 10.1111/j.1399-5618.2012.01033.x

Chitty, 2013, A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder, Eur Neuropsychopharmacol, 23, 1348, 10.1016/j.euroneuro.2013.07.007

Davis, 2015, Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass, Mol Psychiatry, 20, 152, 10.1038/mp.2014.139